Total Payments
$27,900
2024 Payments
$4,017
Companies
92
Transactions
957
Medicare Patients
14,726
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$21,886 (78.4%)
Consulting$2,850 (10.2%)
Other$1,740 (6.2%)
Education$1,418 (5.1%)
Travel$6.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,886 | 909 | 78.4% |
| Consulting Fee | $2,850 | 2 | 10.2% |
| Long term medical supply or device loan | $1,515 | 17 | 5.4% |
| Education | $1,418 | 22 | 5.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $225.00 | 6 | 0.8% |
| Travel and Lodging | $6.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,166 | 88 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,101 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,813 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,452 | 51 | $0 (2024) |
| Genentech USA, Inc. | $1,389 | 48 | $0 (2024) |
| Amgen Inc. | $1,266 | 43 | $0 (2024) |
| PFIZER INC. | $1,231 | 66 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,168 | 55 | $0 (2024) |
| Astellas Pharma US Inc | $902.27 | 24 | $0 (2024) |
| Daiichi Sankyo Inc. | $842.26 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,017 | 175 | PFIZER INC. ($383.36) |
| 2023 | $3,441 | 158 | Novartis Pharmaceuticals Corporation ($435.98) |
| 2022 | $3,639 | 143 | Novartis Pharmaceuticals Corporation ($521.62) |
| 2021 | $3,725 | 126 | Novartis Pharmaceuticals Corporation ($1,316) |
| 2020 | $2,179 | 104 | Astellas Pharma US Inc ($313.25) |
| 2019 | $3,232 | 156 | Genentech USA, Inc. ($594.19) |
| 2018 | $5,078 | 55 | Takeda Pharmaceuticals U.S.A., Inc. ($2,877) |
| 2017 | $2,588 | 40 | Amgen Inc. ($439.30) |
All Payment Transactions
957 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 12/13/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: HEMATOLOGY | ||||||
| 12/09/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Hematology | ||||||
| 12/06/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $39.77 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Oncology | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.64 | General |
| 11/26/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $69.90 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 11/25/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: BioOncology | ||||||
| 11/15/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: CELLT | ||||||
| 11/07/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,740 | 24,039 | $1.2M | $422,283 |
| 2022 | 49 | 3,836 | 33,810 | $1.7M | $538,782 |
| 2021 | 55 | 4,114 | 62,730 | $1.6M | $540,299 |
| 2020 | 42 | 3,036 | 91,276 | $805,864 | $255,666 |
Total Patients
14,726
Total Services
211,855
Medicare Billing
$1.8M
Procedure Codes
194
All Medicare Procedures & Services
194 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 11 | 4,302 | $401,597 | $154,115 | 38.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 2,700 | $100,170 | $49,396 | 49.3% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 23 | 2,400 | $101,088 | $39,909 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 99 | 236 | $60,654 | $30,314 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 228 | $43,676 | $19,173 | 43.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 71 | 594 | $89,100 | $12,399 | 13.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 27 | 122 | $42,213 | $11,097 | 26.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 274 | 777 | $23,473 | $8,033 | 34.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 65 | 152 | $20,357 | $6,964 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $16,466 | $6,860 | 41.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 211 | 488 | $23,766 | $6,507 | 27.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 143 | 218 | $23,069 | $6,323 | 27.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 273 | 794 | $22,065 | $6,036 | 27.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 195 | 353 | $19,016 | $5,217 | 27.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 113 | 529 | $26,979 | $5,060 | 18.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 172 | 307 | $17,880 | $5,053 | 28.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 62 | 546 | $18,144 | $4,976 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 257 | 620 | $4,836 | $4,737 | 97.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 25 | 298 | $18,476 | $4,519 | 24.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 145 | 294 | $15,450 | $4,237 | 27.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 237 | 617 | $13,315 | $3,647 | 27.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 19 | 21 | $13,650 | $3,587 | 26.3% |
| 83550 | Iron binding capacity | Office | 2023 | 139 | 308 | $9,625 | $2,631 | 27.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 108 | $12,960 | $2,227 | 17.2% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 47 | 110 | $7,459 | $2,044 | 27.4% |
About Jack Burton
Jack Burton is a Hematology & Oncology healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700897121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jack Burton has received a total of $27,900 in payments from pharmaceutical and medical device companies, with $4,017 received in 2024. These payments were reported across 957 transactions from 92 companies. The most common payment nature is "Food and Beverage" ($21,886).
As a Medicare-enrolled provider, Burton has provided services to 14,726 Medicare beneficiaries, totaling 211,855 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 194 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Huntersville, NC
- Active Since 08/10/2006
- Last Updated 08/27/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1700897121
Products in Payments
- NINLARO (Drug) $2,936
- KISQALI (Drug) $1,768
- KEYTRUDA (Biological) $1,246
- OPDIVO (Biological) $985.72
- INJECTAFER (Drug) $591.74
- LYNPARZA (Drug) $535.63
- Lenvima (Drug) $500.65
- Perjeta (Biological) $385.90
- TECENTRIQ (Biological) $373.81
- JAKAFI (Drug) $366.57
- XTANDI (Drug) $361.38
- Kyprolis (Biological) $319.05
- Revlimid (Drug) $290.08
- XARELTO (Drug) $284.68
- UKONIQ (Drug) $279.76
- VERZENIO (Drug) $270.84
- CALQUENCE (Drug) $255.09
- XGEVA (Biological) $248.76
- ZEJULA (Drug) $246.47
- IBRANCE (Drug) $242.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Huntersville
John Powderly, M.d, M.D
Hematology & Oncology — Payments: $226,114
Hematology & Oncology $226,114
Timothy Kuo, Md, MD
Hematology & Oncology — Payments: $1,192
Hematology & Oncology $1,192
Jia Hao Liang, Md, MD
Hematology & Oncology — Payments: $795.66
Hematology & Oncology $795.66
Dr. Karim Tazi, Md, MD
Hematology & Oncology — Payments: $493.29
Hematology & Oncology $493.29